XS
Last reporting period 31 Dec, 2023
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.142
Exchange
XSTO - Nasdaq STOCKHOLM AB
-0.033 B
Last period CFO ,SEK
-454%
CFO has decreased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also XSpray Pharma
Company Analysis
XSPRAY.ST valuation, rating, competitors, insights and company profile
Eyestock Rating
XSPRAY.ST financial analysis by Eyestock methodology
Valuation
XSPRAY.ST valuation using historical relative method
Statements
XSPRAY.ST Income Statements, Balance Sheet and Cash Flow Statements
Dividends
XSPRAY.ST dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
XSpray Pharma`s CFO for the period ended 2023-12-31 is -0.033 B SEK
